Summary

Bioreactors Market Size
The global bioreactors market size was valued at $11.98 billion in 2024 and is projected to reach $25.61 billion by 2030, growing at a CAGR of 13.5% during the forecast period.

Bioreactors Overview
Bioreactors are sophisticated devices designed for the controlled cultivation and manipulation of biological systems, particularly cells or microorganisms, to produce various biological products. These reactors provide a controlled environment with parameters such as temperature, pH, oxygen levels, and nutrient supply precisely regulated to optimize the growth and productivity of living organisms. Bioreactors find extensive use in biotechnology, pharmaceuticals, and various research fields to facilitate the cultivation of cells for the production of proteins, enzymes, vaccines, and other bioproducts. The versatility of bioreactors allows for the scaling up of processes from laboratory-scale experiments to large-scale industrial production. They play a crucial role in bioprocessing, offering a sterile and monitored environment that supports the growth and maintenance of living cells, making them essential tools in the development of biopharmaceuticals and other bio-based products.

Bioreactors Market Dynamics
• The bioreactors market is expected to witness significant growth in the future due to the growing demand for effective therapeutics, growing organism cultivation, and the development of preventive vaccines.
• Additionally, the growing demand for biopharmaceuticals and advancements in bioprocessing technologies are the prominent factors driving the growth of the bioreactors market.
• However, the high initial capital investment, regulatory challenges, and raw material shortages are restraining the market growth.
• On the contrary, the increasing investment in research and development and the rising adoption of single-use bioreactors are creating opportunities for market growth.

Impact of COVID-19 on the Bioreactors Market
The COVID-19 pandemic has had a multifaceted impact on the bioreactors market. On one hand, the global demand for biopharmaceuticals and vaccines to combat the virus has surged, leading to increased utilization of bioreactors for the production of these crucial medical interventions. This heightened demand has underscored the importance of scalable and flexible bioprocessing technologies. On the other hand, the pandemic has disrupted supply chains, leading to challenges in the procurement of raw materials and components essential for bioreactor manufacturing. Additionally, the diversion of resources and focus toward COVID-19-related research and production has temporarily slowed down non-COVID bioprocessing activities. The industry has demonstrated resilience by adapting to the changing landscape, with increased emphasis on automation and remote monitoring to ensure continuity in bioreactor operations.

By Product Type, the Single-use Segment is projected to be the Largest Segment in the Bioreactors Market
The single-use segment is projected to be the largest segment in the bioreactors market during the forecast period owing to their scalability, reduced cleaning and validation requirements, and quicker turnaround times they offer, making them particularly advantageous for small to medium-scale production and research applications. Single-use bioreactors offer a more flexible and cost-effective alternative to traditional stainless-steel bioreactors, providing a sterile and disposable environment for cell culture and bioprocessing. The single-use approach minimizes the risk of cross-contamination and allows for seamless transitions between different processes, contributing to increased efficiency in biopharmaceutical production. Additionally, the rising trend toward personalized medicine and the need for more agile manufacturing processes have further fueled the demand for single-use bioreactors. Their convenience, lower upfront investment costs, and adaptability to various bioprocessing needs position them as a preferred choice in the bioreactors market, reflecting a paradigm shift in the industry towards more sustainable and efficient bioprocessing solutions.

By Geography, the North American Region Holds the Dominant Position in the Market Revenue
North American region holds the dominant position in the market revenue due to the robust presence of leading pharmaceutical and biotech companies, coupled with a well-established healthcare infrastructure and a robust regulatory framework. The increasing focus on biopharmaceutical research and development, particularly in the production of monoclonal antibodies, vaccines, and other biologics, has driven the need for advanced bioprocessing technologies, including bioreactors. Moreover, the region's inclination toward technological innovation and a high level of investment in research and development further contributes to the demand for cutting-edge bioreactor systems. The push for personalized medicine and the surge in cell and gene therapy research has also played pivotal roles in driving the demand for bioreactors in North America. As the industry continues to evolve, the region remains at the forefront of bioprocessing advancements, making it a significant and growing market for bioreactor technologies.

Key Target Audience:
• Bioreactor Manufacturers
• Biopharmaceutical Companies
• Research and Development Institutions
• Pharmaceutical and Biotechnology Companies
• Regulatory Authorities
• Academic and Research Organizations
• Contract Research Organizations (CROs)
• Suppliers of Bioreactor Components
• Investors and Financial Institutions
• Healthcare and Life Sciences Associations

List of the Key Players Profiled in the Report Includes:
• GE Healthcare
• Merck KGaA
• Eppendorf AG
• Sartorius AG
• Thermo Fisher Scientific Inc.
• BBI-Biotech GmbH
• Bioengineering AG
• Danaher Corporation
• Getinge
• Infos HT
• Solaris Biotech Solutions

Recent Developments:
• In February 2024, Thermo Fisher Scientific substantially enlarged its biologics manufacturing facility located in St. Louis, Missouri. This expansion has effectively doubled the company's biologics manufacturing capacity at the St. Louis site. The goal is to boost production growth from 2,000 liters to 5,000 liters, facilitating the manufacture of complex biologic treatments targeting various diseases, such as cancer, autoimmune conditions, and rare disorders.
• In December 2022, Merck completed the acquisition of Erbi Biosystems, a Massachusetts-based firm specializing in the development of the 2 ml micro-bioreactor platform technology named "Breez™." This strategic move enhances Merck's upstream portfolio in therapeutic proteins, providing the capability for scalable cell-based perfusion bioreactor processes ranging from 2 ml to 2000L, along with expedited lab-scale process development. The acquisition not only strengthens Merck's position in the field but also opens avenues for future developments in novel modality applications, such as cell therapies..

Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Product Type:
• Glass
• Stainless Steel
• Single-use
Market by, Scale:
• 5L-20L
• 20L-200L
• 200L-1500L
• Above 1500L

Market by, Control Type:
• Manual
• Automated
Market by, Usage:
• Lab-Scale Production
• Pilot-Scale Production
• Full-Scale Production

Market by, Geography:
The bioreactors market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

What Can be Explored with this Research Report:
• Understand the key trends that will drive the market and the challenges it faces in the current market scenario
• Identify growth opportunities
• Porter’s five force analysis
• In-depth analysis of market segments, and regions/countries predicted to observe promising growth
• Historical and forecast size of the market in terms of revenue (USD Million)
• Company profiling with key products and solution offerings, key financial information, SWOT analysis, and business strategies adopted

ページTOPに戻る

Table of Contents

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations

2 Executive Summary

3 Research Methodology

4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges
4.5 Impact of COVID-19 on the Bioreactors Market

5 Porter's Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market

6 Global Bioreactors Market by, Product Type
6.1 Overview
6.2 Glass
6.3 Stainless Steel
6.4 Single-use

7 Global Bioreactors Market by, Scale
7.1 Overview
7.2 5L-20L
7.3 20L-200L
7.4 200L-1500L
7.5 Above 1500L

8 Global Bioreactors Market by, Control Type
8.1 Overview
8.2 Manual
8.3 Automated

9 Global Bioreactors Market by, Usage
9.1 Overview
9.2 Lab-Scale Production
9.3 Pilot-Scale Production
9.4 Full-Scale Production

10 Global Bioreactors Market by, Geography
10.1 Overview
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 New Zealand
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Qatar
10.6.4 Iran
10.6.5 South Africa
10.6.6 Rest of Middle East & Africa

11 Key Developments

12 Company Profiling
12.1 GE Healthcare
12.1.1 Business Overview
12.1.2 Product/Service Offering
12.1.3 Financial Overview
12.1.4 SWOT Analysis
12.1.5 Key Activities
12.2 Merck KGaA
12.3 Eppendorf AG
12.4 Sartorius AG
12.5 Thermo Fisher Scientific Inc.
12.6 BBI-Biotech GmbH
12.7 Bioengineering AG
12.8 Danaher Corporation
12.9 Getinge
12.10 Infos HT
12.11 Solaris Biotech Solutions